JPY2,345.00
1.08%
Tokyo, Sep 05, 08:06 am CET
ISIN
JP3435750009
Symbol
2413
Index

M3 Stock price

JPY2,342.50
+473.50 25.33% 1M
+569.50 32.12% 6M
+945.50 67.68% YTD
+1,017.50 76.79% 1Y
-2,007.50 46.15% 3Y
-3,997.50 63.05% 5Y
+1,120.00 91.62% 10Y
+2,202.50 1,573.21% 20Y
Tokyo, Closing price Fri, Sep 05 2025
+22.50 0.97%
ISIN
JP3435750009
Symbol
2413
Index

Key metrics

Basic
Market capitalization
JPY1.6t
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
38.7 | 33.1
P/S
5.1 | 4.3
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
JPY21.00
Yield 1Y | 5Y
0.9% | 0.3%
Growth 1Y | 5Y
10.5% | 24.6%
Payout 1Y | 3Y
31.5% | 24.1%
Increased
17 Years
Financials (TTM | estimate)
Revenue
JPY306.9b | JPY364.1b
EBITDA
- | JPY87.4b
EBIT
JPY62.9b | JPY15.7b
Net Income
JPY41.1b | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
24.9% | 27.8%
EBITDA
- | 20.1%
EBIT
2.9% | -74.7%
Net Income
-6.9% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
52.7%
EBITDA
- | 24.0%
EBIT
20.5%
Net
13.4% | -
Free Cash Flow
-
Financial Health
Equity Ratio
65.1%
Return on Equity
10.7%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
JPY60.5
FCF per Share
-
Short interest
-
Employees
12k
Rev per Employee
JPY23.6m
Show more

Is M3 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

M3 Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a M3 forecast:

9x Buy
47%
10x Hold
53%

Analyst Opinions

19 Analysts have issued a M3 forecast:

Buy
47%
Hold
53%

Financial data from M3

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
306,891 306,891
25% 25%
100%
- Direct Costs 145,185 145,185
42% 42%
47%
161,706 161,706
13% 13%
53%
- Selling and Administrative Expenses 97,744 97,744
24% 24%
32%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 62,949 62,949
3% 3%
21%
Net Profit 41,076 41,076
7% 7%
13%

In millions JPY.

Don't miss a Thing! We will send you all news about M3 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evidence Solutions segment includes clinical research support business, medical clinical trials management, and management support business. The Overseas segment offers marketing support and research services for medical-related firms in the United States, the United Kingdom, and South Korea. The Clinical Platform segment engages in the development, sale and support of electronic medical records. The Others segment offers information services for medical institutions and prescription drug advertising business. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Itaru Tanimura
Employees 12,100
Founded 2000
Website corporate.m3.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today